Raxibacumab, medically designated as PAmAb ABthrax, represents a groundbreaking therapeutic approach to anthrax . This engineered protein, designed by the company , selectively interacts with the protective https://raxibacumabantiprotectiv502512.newsyblog.com/364411/raxibacumab-a-detailed-exploration-into-the-p-antima-ab-disease